Werewolf Therapeutics: A High-Risk, High-Potential Bet in Cancer Immunotherapy
For investors seeking exposure to the biotech sector, Werewolf Therapeutics, Inc. (NASDAQ: HOWL) presents a compelling, albeit speculative, opportunity. Based in Watertown, Massachusetts, and founded in 2017 by industry veterans Daniel J. Hicklin, Patrick A.…









